SK279339B6 - Racemické alebo opticky aktívne bis-aza-bicyklické - Google Patents

Racemické alebo opticky aktívne bis-aza-bicyklické Download PDF

Info

Publication number
SK279339B6
SK279339B6 SK299-90A SK29990A SK279339B6 SK 279339 B6 SK279339 B6 SK 279339B6 SK 29990 A SK29990 A SK 29990A SK 279339 B6 SK279339 B6 SK 279339B6
Authority
SK
Slovakia
Prior art keywords
formula
group
compound
preparation
optically active
Prior art date
Application number
SK299-90A
Other languages
English (en)
Slovak (sk)
Inventor
Kishor A. Desai
Gene M. Bright
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of SK279339B6 publication Critical patent/SK279339B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
SK299-90A 1989-01-23 1990-01-22 Racemické alebo opticky aktívne bis-aza-bicyklické SK279339B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1989/000275 WO1990008148A1 (en) 1989-01-23 1989-01-23 Bis-aza-bicyclic anxiolytic agents
PCT/US1989/003811 WO1990008144A1 (en) 1989-01-23 1989-09-01 Bis-aza-bicyclic anxiolytic agents

Publications (1)

Publication Number Publication Date
SK279339B6 true SK279339B6 (sk) 1998-10-07

Family

ID=22214801

Family Applications (1)

Application Number Title Priority Date Filing Date
SK299-90A SK279339B6 (sk) 1989-01-23 1990-01-22 Racemické alebo opticky aktívne bis-aza-bicyklické

Country Status (38)

Country Link
US (1) US5122525A (bs)
EP (1) EP0380217B1 (bs)
JP (1) JPH0643427B2 (bs)
KR (1) KR910009289B1 (bs)
CN (1) CN1022186C (bs)
AP (1) AP128A (bs)
AR (1) AR246969A1 (bs)
AT (1) ATE82574T1 (bs)
AU (1) AU614214B2 (bs)
BA (1) BA98302A (bs)
BG (1) BG51046A3 (bs)
CA (1) CA2008108C (bs)
CZ (1) CZ277698B6 (bs)
DD (1) DD291560A5 (bs)
DE (1) DE69000467T2 (bs)
DK (1) DK0380217T3 (bs)
EG (1) EG19306A (bs)
ES (1) ES2053094T3 (bs)
FI (1) FI95381C (bs)
GR (1) GR3006925T3 (bs)
HU (1) HU215154B (bs)
IE (1) IE62670B1 (bs)
IL (1) IL93073A (bs)
IS (1) IS1667B (bs)
MA (1) MA21735A1 (bs)
MX (1) MX19222A (bs)
MY (1) MY104861A (bs)
NO (1) NO175978C (bs)
NZ (1) NZ232168A (bs)
OA (1) OA10041A (bs)
PL (1) PL163836B1 (bs)
PT (1) PT92919B (bs)
RO (1) RO110142B1 (bs)
RU (1) RU2015977C1 (bs)
SK (1) SK279339B6 (bs)
WO (2) WO1990008148A1 (bs)
YU (1) YU47554B (bs)
ZA (1) ZA90430B (bs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
WO1992000075A1 (en) * 1990-06-29 1992-01-09 Pfizer Inc. Pyridopyrazine derivatives for treating substance abuse and addiction
DE69108743T2 (de) * 1991-01-31 1995-08-17 Pfizer Recematspaltung von trans-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2h-pyrido[1,2-a]-pyrazin.
US5185449A (en) * 1991-02-27 1993-02-09 Pfizer Inc. Process and intermediate for certain bis-aza-bicyclic anxiolytic agents
CA2101252C (en) * 1991-02-27 1998-02-17 Frank J. Urban Process for preparing trans-piperidine-2,5- dicarboxylates
US5157034A (en) * 1991-02-27 1992-10-20 Pfizer Inc. Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
US5311195A (en) * 1991-08-30 1994-05-10 Etak, Inc. Combined relative and absolute positioning method and apparatus
ES2096099T3 (es) * 1991-09-25 1997-03-01 Pfizer Perhidro-1h-pirido(1,2,a)pirazinas 2-sustituidas neurolepticas.
EP0646116B1 (en) * 1992-06-16 1999-10-13 Pfizer Inc. Process and intermediates for bis-aza-bicyclic anxiolytic agents
WO1994006794A1 (en) * 1992-09-24 1994-03-31 National Institutes Of Health Aralkyl diazabicycloalkane derivatives for cns disorders
IL104506A (en) * 1993-01-25 1997-11-20 Israel State Fast changing heating- cooling device and method, particularly for cryogenic and/or surgical use
US5637713A (en) * 1993-08-20 1997-06-10 Pfizer Inc. Process for preparing trans-piperidine-2,5-dicarboxylates
US5455350A (en) * 1993-10-13 1995-10-03 Pfizer Inc. Process and intermediate for certain bis-aza-bicyclic anxiolytic agents
IL107460A (en) * 1993-11-01 1999-06-20 Israel State Controlled cryogenic contact system
CN1068327C (zh) * 1994-09-30 2001-07-11 辉瑞大药厂 2,7－取代的八氢－1H－吡啶并[1,2－a]吡嗪衍生物
US5731307A (en) * 1994-09-30 1998-03-24 Pfizer, Inc. Neuroleptic 2,7-disubtituted perhydro-1h-pyrido 1, 2-A!pyrazines
US6231833B1 (en) 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
WO1997023482A1 (en) * 1995-12-21 1997-07-03 Pfizer Inc. 2,7-substituted octahydro-pyrrolo[1,2-a]pyrazine derivatives
BR9710018A (pt) * 1996-07-01 1999-08-10 Pfizer Preparação de (7S,trans)-2-(2-pirimidinil)-7-(hidroximetil)octa-hidro-2H-pirido[1,2-A]pirazina
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
US6251893B1 (en) * 1998-06-15 2001-06-26 Nps Allelix Corp. Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity
HN1999000146A (es) * 1998-09-21 2000-11-11 Pfizer Prod Inc Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.
US20020016334A1 (en) * 2000-07-31 2002-02-07 Coe Jotham Wadsworth Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD)
US6670476B2 (en) 2000-11-29 2003-12-30 Pfizer Inc. Resolution of trans-7-(hydroxy-methyl)octa-hydro-2H-pyrido[1,2-a]pyrazine
KR20070074667A (ko) * 2003-03-12 2007-07-12 화이자 프로덕츠 인크. 피리딜옥시메틸 및 벤즈이속사졸 아자비시클릭 유도체
DE602004018637D1 (de) 2003-04-09 2009-02-05 Biogen Idec Inc A2a-adenosinrezeptorantagonisten
CA2547283C (en) * 2003-11-26 2010-11-09 Pfizer Products Inc. Aminopyrazole derivatives as gsk-3 inhibitors
EP1753430A2 (en) * 2004-05-27 2007-02-21 Warner-Lambert Company LLC Combination of atomoxetine and a 5ht1a receptor agonist for treating adhd and other disorders
US7658206B2 (en) 2006-12-05 2010-02-09 Kohler Co. Plumbing valve with stick control handle

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4339579A (en) * 1980-12-29 1982-07-13 American Home Products Corporation 2,6-Bis-(pyrrolopyrazinyl)pyrazines
US4400511A (en) * 1982-05-07 1983-08-23 American Home Products Corporation 2-Substituted octahydropyrrolo(1,2-A)-pyrazine-3-carboxylic acids
US4414389A (en) * 1982-05-25 1983-11-08 American Home Products Corporation 4-Substituted-piperidino carboxamides
US4517187A (en) * 1982-10-18 1985-05-14 Pennwalt Corporation 1,3,4,6,7-11b-Hexahydro-7-phenyl-2H-pyrazino[2,1-a]isoquinolines methods of preparation, and use as antidepressants
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3409440A1 (de) * 1984-03-15 1985-09-26 Bayer Ag, 5090 Leverkusen Imidazo(1,5-a)pyridyl-methan- und imidazo(1,5-b)pyridazinylmethan-derivate, ihre herstellung und sie enthaltende aufzeichnungsmaterialien
IT1204803B (it) * 1986-02-17 1989-03-10 Acraf Composto farmacologicamente attivo e composizioni farmaceutiche che lo contengono,procedimento per prepararlo e intermedio utile in detto procedimento
US4788290A (en) * 1987-12-11 1988-11-29 American Home Products Corporation Serotonergic pyrazine derivatives
JP2668259B2 (ja) * 1988-02-18 1997-10-27 塩野義製薬株式会社 複素環化合物および抗潰瘍剤
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents

Also Published As

Publication number Publication date
OA10041A (en) 1996-10-14
DK0380217T3 (da) 1992-12-14
NO912863D0 (no) 1991-07-22
MA21735A1 (fr) 1990-10-01
IS3529A7 (is) 1990-07-24
NO175978C (no) 1995-01-11
GR3006925T3 (bs) 1993-06-30
CA2008108A1 (en) 1990-07-23
ES2053094T3 (es) 1994-07-16
IE900225L (en) 1990-07-23
AP128A (en) 1991-03-20
AU614214B2 (en) 1991-08-22
FI95381C (fi) 1996-01-25
PT92919B (pt) 1995-12-29
JPH02233681A (ja) 1990-09-17
CS29990A3 (en) 1992-11-18
NO912863L (no) 1991-07-22
CN1022186C (zh) 1993-09-22
MX19222A (es) 1993-12-01
AP9000158A0 (en) 1990-01-31
PL163836B1 (pl) 1994-05-31
NZ232168A (en) 1991-08-27
US5122525A (en) 1992-06-16
CN1044464A (zh) 1990-08-08
YU47554B (sh) 1995-10-03
BG51046A3 (en) 1993-01-15
FI95381B (fi) 1995-10-13
DE69000467T2 (de) 1993-04-01
EP0380217B1 (en) 1992-11-19
PT92919A (pt) 1990-07-31
DD291560A5 (de) 1991-07-04
RO110142B1 (ro) 1995-10-30
EG19306A (en) 1995-01-31
CA2008108C (en) 1995-08-08
WO1990008148A1 (en) 1990-07-26
ATE82574T1 (de) 1992-12-15
HU215154B (hu) 2000-09-28
IL93073A (en) 1994-05-30
KR910009289B1 (ko) 1991-11-09
YU11190A (sh) 1993-05-28
KR900011774A (ko) 1990-08-02
AR246969A1 (es) 1994-10-31
JPH0643427B2 (ja) 1994-06-08
IE62670B1 (en) 1995-03-08
FI913510A0 (fi) 1991-07-22
BA98302A (bs) 2001-09-14
ZA90430B (en) 1991-08-28
DE69000467D1 (de) 1992-12-24
CZ277698B6 (en) 1993-03-17
HUT63163A (en) 1993-07-28
IS1667B (is) 1997-11-14
AU4867990A (en) 1990-07-26
EP0380217A1 (en) 1990-08-01
WO1990008144A1 (en) 1990-07-26
RU2015977C1 (ru) 1994-07-15
MY104861A (en) 1994-06-30
NO175978B (no) 1994-10-03

Similar Documents

Publication Publication Date Title
SK279339B6 (sk) Racemické alebo opticky aktívne bis-aza-bicyklické
EP0017484B1 (en) 2-imidazoline derivatives, process for the preparation thereof and the pharmaceutical composition of the same
EP0132375B1 (en) Dihydropyridine anti-ischaemic and antihypertensive agents
DE69329654T2 (de) 3-oxo-pyrido [1,2-a] benzimidazol-4-carboxyl und 4-oxo-azepino [1,2-a] benzimidazol-5-carboxyl derivate geeignet für die behandlung von zentralnervensystemerkrankungen
EP0222474B1 (en) Gamma-carbolines
KR890000706B1 (ko) 1,6-나프티리딘 유도체의 제조방법
AU651977B2 (en) Pyridopyrazine derivatives for treating substance abuse and addiction
EP0174136B1 (en) Derivatives of dihydro-1h-pyrrolo(1,2-c)imidazol-3,5-dione as cognition activators
EP0254527B1 (en) Tetracyclic indole derivatives
WO2023213525A1 (en) 2-(5-FLUORO-1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-b]PYRIDIN-3-YL)-5-NITROSOPYRIMIDIN-4,6-DIAMINE OR A SALT THEREOF, METHOD FOR THE PREPARATION THEREOF, AND USE THEREOF IN THE SYNTHESIS OF VERICIGUAT
EP1380585B1 (en) Pyrazolopyridinone as intermediate
LU83251A1 (fr) Derives d'imidazo(4,5-b)pyridine,leur preparation et leur utilisation comme agents cardiotoniques
EP1048667A1 (en) Process for preparing 8-cyclopentyl-6-ethyl-3-(substituted)-5,8-dihydro-4H-1,2,3A,7,8-pentaaza-as-indacenes and intermediates useful therein
HU211986A9 (hu) Szorongásoldó hatású bisz-azabiciklo-vegyületek
NL8302297A (nl) E-homoeburnaanderivaten, werkwijze voor hun bereiding, alsmede farmaceutische samenstellingen welke deze verbindingen bevatten.